Antiarrhythmic 'Propanorm'. Ntuziaka maka ojiji

Nkwadebe "Propanorm" ntụziaka ntuziaka na-akọwa dị ka ihe antiarrhythmic gị n'ụlọnga na-ike igbochi ngwa ngwa sodium ọwa. The n'ọrụ mgwa bụ ọgwụ propafenone.

Agwọ ọrịa "Propanorm" na-agbala n'ụdị gburugburu biconvex mbadamba nke na-ntekwasa, o nwere a na-acha ọcha ma ọ bụ fọrọ nke nta na-acha ọcha na agba.

The ọgwụ netwọk pụtara ọnọ katọn ngwugwu nwere ise blisters. Onye ọ bụla n'ime ha, n'aka, nwere iri mbadamba.

The ọgwụ ike zụrụ na bụla ahịa ọgwụ, ma naanị site ọgwụ.

Site na ojiji nke ọgwụ ọjọọ, "Propanorm" (ntuziaka e dere ozi banyere na) nwere ike kenyere a dọkịta na ndị na-esonụ mgbe:

• Maka ọgwụgwọ nke supraventricular na ventricular arrhythmia.
• N'ihi mgbochi, ma ọ bụrụ na e nwere paroxysmal n'afọ iri na ụma nsogbu, nakwa dị ka ha ọgwụgwọ.
• N'ihi mgbochi na ọgwụgwọ nke atrio-ventricular tachycardia.
• N'ihi mgbochi, ma ọ bụrụ na e nwere na-akwagide monomorphic ventricular tachycardia.

Na echiche nke ndị dị oké njọ nke ebe ọgwụ nakwa dị ka ya elu ọrụ, Propanorm kenyere na ịkpachara anya ka ọrịa ndị na-ata ahụhụ site na ọrịa na-anaghị ekwe ka ndị a:

• myasthenia gravis;
• obi odida;
• cardiomyopathy;
• hypotension;
• hepatic cholestasis;
• hepatic ma ọ bụ gbasara akụrụ odida;
• electrolyte abnormalities;
• nká (mgbe afọ 70);
• a na-adịgide adịgide ma ọ bụ ruo nwa oge pacemaker;
• ngalaba-ochichi nke ọzọ antiarrhythmic ọgwụ ọjọọ.

Ke adianade mmasị ka ọgwụ ọjọọ, "Propanorm" ntụziaka ntuziaka adọ aka ná ntị nke contraindications, nke dị mkpa ịtụle iji ọgwụ maka ọgwụgwọ. Ọ bụghị na-atụ aro iji ọgwụ ọjọọ eme ihe omume na-enwe ndidi nwere adịghị ala ala obi ọdịda, na oké ma ọ bụ oké ụdị bradycardia. State of cardiogenic ujo na myocardial infarction. Ọzọkwa, mgbe ọbara hypotension na a syndrome nke "tachycardia-bradycardia", na a ọnụ ọgụgụ nke ndị ọzọ dị oké njọ ọrịa obi mpaghara.

Ọ bụ uru na-arịba ama na ojiji nke ọgwụ ọjọọ na-contraindicated bụghị naanị na ọrịa, ma n'ihi na nwa ara na nne, na ụmụ na-eto eto, dị ka nke ọma dị ka onye ọ bụla bụ anabataghi nke ọ bụla n'ọnụ mmiri.

Dị ka ọ bụla ọzọ ọgwụ, mbadamba "Propanorm" (ntụziaka ntuziaka mejupụtara ihe ọmụma banyere nke a) nwere mmetụta na nwere ike imetụta obi, digestive, Central ụjọ, omumu usoro na hemopoietic usoro. Ekwe Omume pụta nke eji ego a wee ghọọ anabata, oké nke adịghị ike na bronchospasm.

Otú ọ dị, ọ bụrụ na dọkịta chọpụtara na ọ dị mkpa ka ọ họpụta a ọgwụ maka ọgwụgwọ nke "Propanorm" ole aṅụ mbadamba na ihe oge na-, ọzọ ozugbo ntụziaka.

Ọ bụ ezie na dosing Usoro nwere ike ịgbanwe n'otu n'otu n'ihi na onye ọ bụla ndidi na gbanwere a dọkịta.

Dị ka ntụziaka, bụ mbadamba nkume kwesịrị iwere mgbe a nri, ilo ha dum, ọ bụghị-ata ata ma ọ bụ na-aṅụ mmiri obere obere.

The amalite dose bụ 450 mg kwa ụbọchị, nke a ga-ekewa atọ nzọụkwụ. Mgbe ahụ, ọ pụrụ iji nwayọọ nwayọọ na-amụba (ruo 900 milligrams).

Iji zere ihe ovadozu nke ọgwụ na ọgwụgwọ nke "Propanorm" ntuziaka maka ojiji ga-nlezianya atụle site gị dị ka ọ na e dere ihe ọmụma zuru ezu banyere otú ọgwụ. Mgbe niile, ọbụna na otu-ogbo na-ewere ọgwụ ọ dịkarịa ala ugboro abụọ na gānagide kwa ụbọchị oriri, igbu egbu na-egosipụta onwe n'ime otu awa. Kpatara ịṅụfe ọgwụ ike ókè pụrụ ịbụ nnọọ oké njọ.

Ya mere Propanorm ga-echekwara na a ebe nke bụ keerughi ụmụ. The ebe kwesịrị akọrọ ma na-echebe site kpọmkwem ìhè anyanwụ. The nkwadebe nwere ike ịchekwa na ụlọ okpomọkụ n'ihi na ihe karịrị afọ abụọ.